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Abstract 
Background: Esophageal cancer is one of the world’s top ten cancers. Its incidence, especially in the form of squa-
mous cell carcinoma, is very high in some Asian regions including Kashmir. Jammu Kashmir and Ladakh are three 
provinces of Jammu and Kashmir, the northern most state of India. The three regions represent ethnically diverse 
socio-cultural populations with different incidences of esophageal squamous cell carcinoma (ESCC), a suitable setting 
for epidemiological studies. Hence, comparing the lifestyle, dietary habits and gene pools between the three regions 
will help in elucidation of ESCC etiology further. Therefore, to assess the possibility of conducting a larger case control 
study, we carried out a feasibility study to identify the collaborators as well as to explore patient referral systems and 
available research facilities in the state.
Findings: We found conducting good cancer molecular epidemiology studies is difficult due to lack of proper 
research facilities and favourable administrative guidelines. The appropriate storage, transportation and analyses 
facilities of biological specimens for genome-wide association study and assessment of nutrition and exposure 
markers are unavailable or not sufficiently developed. Guidelines that can encourage scientific collaborations within 
the country seem unavailable. However, the administrative guidelines available under which the export of biological 
specimens out of India for analysis seems impossible. Consequently, Indian researchers are unable to collaborate with 
foreign scientists and render state of art research facilities inaccessible to them. Scientists in other parts of India may 
also confront with most of these impediments.
Conclusion: The study found that for conducting conclusive molecular epidemiological studies in India, referral 
system in hospitals is not systematic, scientific research facilities are inadequate as well as the guidelines for foreign 
collaboration  are not favourable.
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Background
Esophageal cancer is the eighth most common malig-
nancy worldwide and the sixth most common cause 
of cancer deaths (Ferlay et  al. 2010). Kashmir Valley, 
the northern most part of India (Figure  1), lies at the 
southern edge of “Asian esophageal cancer belt” with 
a moderately high incidence of esophageal squamous 
cell carcinoma (ESCC) (Khuroo et  al. 1992). Even 
though several factors have been associated with 
ESCC risk in the belt including Kashmir (Tran et  al. 
2005; Dar et al. 2012, 2013a, b; Yu et al. 2010; Kaman-
gar et  al. 2009; Nasrollahzadeh et  al. 2008), its etiol-
ogy is still not completely understood. Hence, to gain 
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deeper insight into the etiology of ESCC, more studies 
on various potential genetic and environmental factors 
are warranted.
Jammu and Kashmir (J&K) state, consists of three 
ethnically different regions; Jammu, Kashmir and 
Ladakh. The inhabitants of these three regions differ in 
Figure 1 Physical map of India.
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socio-religious backgrounds, life-style, economy and die-
tary habits and more importantly have a huge differences 
in ESCC incidence. Jammu and Ladakh regions have very 
low incidence of ESCC while Kashmir has the highest 
incidence of ESCC among all the cancers and amongst 
the three regions (Romero-Gallo et  al. 2002; Khuroo 
et al. 1992). Thus these three heterogeneous populations 
of J&K provide a suitable setting for conducting epide-
miological studies on ESCC. In order to assess the pos-
sibility of conducting a big case–control study on ESCC 
in J&K, a feasibility study (FS) was undertaken to focus 
on: (1) establishing a collaboration between the clinicians 
and scientists, (2) building a referral set-up for identifi-
cation, diagnosis and recruitment of cases, (3) adapting, 
pre-testing and validation of dietary and lifestyle ques-
tionnaires for study populations and (4) assessing the 
possibility of collection, storage, transportation and anal-
yses of biological specimens for various purposes includ-
ing genome-wide association study (GWAS).
Methods
Referral and speciality set‑up and potential  
for establishing collaborations
The main hospitals from where the cases were recruited 
are Government Medical Colleges of Jammu and Srina-
gar and SK-Institute of Medical Sciences (SKIMS), Srina-
gar which caters the needs from diagnosis to treatment of 
all cancer patients in the state of J&K. The district hospi-
tals all across J&K refer suspected cancer cases to these 
hospitals. In Ladakh, no tertiary care hospital is available 
and cancer patients who visit the existing district hospi-
tals are referred either to Srinagar or Jammu hospitals. 
To ensure maximum inclusion of incident cases of ESCC 
and to obtain individually matched controls, all the hos-
pitals were to be brought into the collaborative network 
to form a base for the referral system linking district hos-
pitals all across the state to speciality hospitals. All the 
hospitals were contacted for formal collaboration mainly 
for subject recruitment and referrals. The state lacks 
private clinics which can provide tertiary care to cancer 
patients and therefore, were not considered. The study 
was approved by the institutional ethical committees of 
SKIMS Srinagar and GMC Jammu.
Design and pre‑testing of questionnaires
The questionnaires [main and food frequency question-
naires (FFQ)] used for Jammu and Ladakh regions were 
based on, and modified from those developed for two 
case control studies conducted recently in the two belt 
regions; Golestan, Iran (Malekshah et al. 2006) and Kash-
mir (Dar et al. 2012). The comprehensive questionnaires 
were modified and pre-tested by interviewing patients, 
as well as attendants and medical staff in the hospitals 
to evaluate the suitability of the questionnaires for these 
provinces of the state. For Kashmir, we adopted the ques-
tionnaires already designed and tested during our earlier 
study (Dar et al. 2012). The demographic, socioeconomic 
and lifestyle related information was obtained by using 
main questionnaire and FFQ was used to collect informa-
tion on the consumption of various food items.
Biological specimen collection, transportation and analysis
It was also important to evaluate the feasibility of col-
lection of quality biological specimens including blood, 
urine and tissues. The specimen needed to be either pro-
cessed immediately or transported and stored for further 
analysis at very low temperatures. The proposed analyses 
of the biological specimens were for: (a) genetic mark-
ers by genome wide association approach, (b) exposure 
markers/carcinogens like nitrosamines and PAH, (c) 
expression markers in cancer tissues, and (d) validation 
of the food frequency questionnaire by measuring nitro-
gen, potassium, vitamin A and C, carotenoids, fatty acids, 
etc. It was planned to get most of the analysis done in 
partner institutions, IARC, France and NCI, USA.
Validation of FFQ
We preferred to validate the FFQ by assessing the nutri-
tional markers in the body fluids because the measure-
ment errors of the nutritional markers are least in this 
method. We choose the weekly-method to validate the 
pretested FFQ. Fifty healthy residents from the different 
districts were included by administering weekly, the 24 h 
dietary recall and main FFQ over a period of 6  weeks, 
besides collecting biological samples viz blood and urine 
(for details of FFQ validation, please see Additional file 1: 
Text T1). The 24-h dietary recalls have good quality 
response rate and do not interfere much with the normal 
dietary habits of the subjects and were therefore, chosen 
as the reference method for the FFQ validation (Bohlsc-
heid-Thomas et al. 1997).
Results
On exploring the possibility of working together with 
medical centres, we were not able to establish collabora-
tion with most of the medical centres in J&K. The major-
ity of the clinicians particularly in Ladakh region were 
not ready to participate in the study. We could not find 
any defined procedure to be followed or specific officials/
offices to be approached, to set up a collaboration with 
hospitals. Even the clinicians who were interested to 
collaborate were skeptical under such vague situations. 
However, we could recruit 24/50, 2/10 and 50/100 cases/
controls from Jammu, Ladakh and Kashmir, respectively. 
Subjects with histological confirmation of ESCC were 
enrolled as cases. There is no state cancer register though 
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hospital cancer registries were available at SKIMS and 
GMC Jammu only.
Collection of biological specimens was possible from 
most of the places as the para medical staff, including 
nurses cooperated and majority of the subjects con-
sented to participate. Storage facilities for biological 
specimens was not available in the district hospitals 
except deep freezers (−20°C) in some hospitals which 
are used for blood storage. However, at SKIMS, GMC 
Jammu and Srinagar deep freezers (−80°C) are avail-
able in a few supporting departments. Transportation 
of specimens at low temperatures from the place of col-
lection to Kashmir University for storage and process-
ing was very difficult in the existing setup. No proper 
biobanking facility is available in Kashmir University and 
even storing the specimen at low temperatures (−80°C) 
for a longer time is not without a risk due to electricity 
cuts and lack of backup.
It was foreseen that storage of biological materials will 
be mirrored and analysed at the International Agency 
for Research on Cancer (IARC) and partner institu-
tions. However, the analysis of the specimen for genetic, 
nutritional and exposure markers in foreign laboratories 
was not possible because of procedural limitations. (For 
details of the permission process to export samples out of 
India, please see Additional file 1: Text T2). We explored 
the possibility of analysing specimen in India also by con-
tacting various laboratories including Dr Lal Path Labs 
New Delhi and Quest Diagnostics India Pvt. Ltd (QDI). 
These laboratories could offer specimen analyses for a 
few nutritional markers only.
Discussion
We found conducting good cancer molecular epidemi-
ology studies in India is difficult due to lack of proper 
research facilities and administrative support. Establish-
ing collaboration for subject recruitment (or their refer-
rals) and analyses of biological specimen for genetic, 
nutritional and exposure markers, in foreign labs, seems 
difficult.
Establishing collaborations with potential partners 
was a very difficult exercise. The guidelines and proce-
dures for collaboration are not available. Some clinicians 
are overburdened which limits their participation in 
research, while as a section of them lacks preference or 
motivation for their important role in clinical research. 
The administration seems unaware of the importance 
of such studies in the health sector. Without the active 
participation of the medical fraternity and administra-
tion, conducting conclusive epidemiological and other 
related studies is impossible. Clinicians need motivation 
and realization of the immense importance of undertak-
ing or participating in public health studies. It remains a 
challenge for India to develop new models for world-class 
molecular and environmental epidemiology research 
involving a strong connection between research insti-
tutes and medical centers. Although, there are guidelines 
from the Medical Council of India which emphasize that 
quality research and publications be the determinants of 
career advancements, yet there is a lot more to be done 
to make such guidelines more effective.
Lack of proper identification and registration of can-
cer patients in the state is another concern. The exist-
ing hospital based cancer registries are incomplete and 
incoherent in details. This limits the possibility of track-
ing patients, registering all incident cases without dupli-
cation and linking tertiary hospitals with primary and 
secondary care centres. Hospitals need to be linked, data 
needs to be shared confidentially and new computer pro-
grams and unique registration numbers need to be devel-
oped to track and avoid any duplications.
GWAS and assessment of exposure and nutritional 
markers all need quality bio-specimens, as well as state 
of the art technology and instrumentation. Limitation 
of sample storage, transportation at required low tem-
peratures and more importantly lack of infrastructure 
to analyse them are serious issues. In the absence of 
these facilities, we could have analysed samples out-
side India but it was not feasible because of stringent 
procedural guidelines. Only 10% of samples of a study 
could be transported outside the country under exist-
ing guidelines, which cannot help to reach conclusive 
findings.
Hence we need to develop state of the art, cutting edge 
and high through put technology to bring our institu-
tions at par with developed world. We need to make an 
introspection of our policies and guidelines for analys-
ing the biological specimens in overseas labs. Although 
we realise that providing more resources and strengthen-
ing the national infrastructure for scientific research, can 
only be solved through time, yet deferring research in the 
health sector can be detrimental. In view of the immense 
importance and priority for biomedical research it will 
be advisable to get benefits of the advanced technology 
available in other countries.
Conclusion
It is possible to conduct a large-scale conclusive molecu-
lar epidemiology study in Jammu and Kashmir and other 
regions of India, if policies and guidelines are framed to 
encourage national and foreign scientific collaboration. 
Interlinking the hospitals, proper patient registration 
and referral system on a modern basis should be initi-
ated. Additionally, basic research infrastructure needs 
improvement and modern scientific laboratories should 
be established.
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